These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34816362)

  • 1. Obesity phenotypes are, in part, associated with physical activity in diabetic hemodialysis patients.
    de Oliveira Matos B; da Costa Rosa CS; Ribeiro HS; Marcos NM; Losilla MPR; Monteiro HL; Gimenes C
    Int Urol Nephrol; 2022 Jul; 54(7):1751-1759. PubMed ID: 34816362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worsening Disability and Hospitalization Risk in Sarcopenic Obese and Dynapenic Abdominal Obese: A 5.5 Years Follow-Up Study in Elderly Men and Women.
    Rossi AP; Urbani S; Fantin F; Nori N; Brandimarte P; Martini A; Zoico E; Mazzali G; Babbanini A; Muollo V; Zamboni M
    Front Endocrinol (Lausanne); 2020; 11():314. PubMed ID: 32695067
    [No Abstract]   [Full Text] [Related]  

  • 3. Associations of Sarcopenic Obesity and Dynapenic Obesity with Bone Mineral Density and Incident Fractures Over 5-10 Years in Community-Dwelling Older Adults.
    Scott D; Chandrasekara SD; Laslett LL; Cicuttini F; Ebeling PR; Jones G
    Calcif Tissue Int; 2016 Jul; 99(1):30-42. PubMed ID: 26939775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Dynapenic Obesity and Sarcopenic Obesity with the Risk of Complications in COVID-19.
    Pérez-Campos Mayoral L; Matias-Cervantes CA; Pérez-Campos E; Romero Díaz C; Laguna Barrios LÁ; Pina Canseco MDS; Martínez Cruz M; Pérez-Campos Mayoral E; Solórzano Mata CJ; Rodal Canales FJ; Martínez Ruíz H; Hernández-Huerta MT
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant Association of Diabetes With Mortality of Chronic Hemodialysis Patients, Independent of the Presence of Obesity, Sarcopenia, and Sarcopenic Obesity.
    Ishimura E; Okuno S; Nakatani S; Mori K; Miyawaki J; Okazaki H; Sugie N; Norimine K; Yamakawa K; Tsujimoto Y; Shoji S; Inaba M; Yamakawa T; Emoto M
    J Ren Nutr; 2022 Jan; 32(1):94-101. PubMed ID: 34465504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive impact of obesity on the prognosis of liver cirrhosis.
    Endo K; Kakisaka K; Abe T; Yusa K; Nakaya I; Watanabe T; Suzuki A; Yoshida Y; Oikawa T; Miyasaka A; Kuroda H; Matsumoto T
    J Gastroenterol Hepatol; 2024 Aug; 39(8):1663-1672. PubMed ID: 38700075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenic obesity and dynapenic obesity: 5-year associations with falls risk in middle-aged and older adults.
    Scott D; Sanders KM; Aitken D; Hayes A; Ebeling PR; Jones G
    Obesity (Silver Spring); 2014 Jun; 22(6):1568-74. PubMed ID: 24585708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Sarcopenia and Dynapenia and Related Clinical Outcomes in Patients with Type 1 Diabetes Mellitus.
    Andreo-López MC; Zarco-Martín MT; Contreras-Bolívar V; Fernández-Soto ML
    Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Sarcopenia and Sarcopenic Obesity With Metabolic Syndrome Considering Both Muscle Mass and Muscle Strength.
    Lee J; Hong YP; Shin HJ; Lee W
    J Prev Med Public Health; 2016 Jan; 49(1):35-44. PubMed ID: 26841883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression Severity as a Risk Factor of Sarcopenic Obesity in Morbidly Obese Patients.
    Venant V; Pouget M; Lahaye C; Gentes E; Pereira B; Lambert C; Debarges J; Domingues-Faria C; Palmier-Forestier C; Farigon N; Miolanne M; Boirie Y
    J Nutr Health Aging; 2019; 23(8):761-767. PubMed ID: 31560036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of sarcopenia and dynapenia in CKD predialysis patients with EGWSOP2 criteria: An observational, cross-sectional study.
    Guida B; Maro MD; Lauro MD; Lauro TD; Trio R; Santillo M; Belfiore A; Memoli A; Cataldi M
    Nutrition; 2020 Oct; 78():110815. PubMed ID: 32480255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynapenic-obesity and physical function in older adults.
    Bouchard DR; Janssen I
    J Gerontol A Biol Sci Med Sci; 2010 Jan; 65(1):71-7. PubMed ID: 19887536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenic obesity is associated with macroalbuminuria in patients with type 2 diabetes: a cross-sectional study.
    Takahashi F; Hashimoto Y; Kaji A; Sakai R; Okamura T; Hamaguchi M; Fukui M
    Endocr J; 2021 Jul; 68(7):781-789. PubMed ID: 33731539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of back muscle strength and sarcopenia-related parameters in the patients with spinal disorders.
    Toyoda H; Hoshino M; Ohyama S; Terai H; Suzuki A; Yamada K; Takahashi S; Hayashi K; Tamai K; Hori Y; Nakamura H
    Eur Spine J; 2019 Feb; 28(2):241-249. PubMed ID: 30542935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: Findings from the Impact of Diabetes Mellitus on Dynapenia study.
    Mori H; Kuroda A; Yoshida S; Yasuda T; Umayahara Y; Shimizu S; Ryomoto K; Yoshiuchi K; Yamamoto T; Matsuoka TA; Shimomura I; Matsuhisa M
    J Diabetes Investig; 2021 Jun; 12(6):1050-1059. PubMed ID: 33063949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association between Body Composition Phenotype and Insulin Resistance in Post-COVID-19 Syndrome Patients without Diabetes: A Cross-Sectional, Single-Center Study.
    González-Islas D; Flores-Cisneros L; Orea-Tejeda A; Keirns-Davis C; Hernández-López N; Arcos-Pacheco LP; Zurita-Sandoval A; Albarran-López F; García-Castañeda L; Salgado-Fernández F; Hernández-López S; Jiménez-Valentín A; Pérez-García I
    Nutrients; 2024 Jul; 16(15):. PubMed ID: 39125348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between diabetic neuropathy and sarcopenia.
    Yasemin Ö; Seydahmet A; Özcan K
    Prim Care Diabetes; 2019 Dec; 13(6):521-528. PubMed ID: 31126745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynapenic obesity and the effect on long-term physical function and quality of life: data from the osteoarthritis initiative.
    Batsis JA; Zbehlik AJ; Pidgeon D; Bartels SJ
    BMC Geriatr; 2015 Oct; 15():118. PubMed ID: 26449277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-sectional associations of objectively measured physical activity and sedentary time with sarcopenia and sarcopenic obesity in older men.
    Aggio DA; Sartini C; Papacosta O; Lennon LT; Ash S; Whincup PH; Wannamethee SG; Jefferis BJ
    Prev Med; 2016 Oct; 91():264-272. PubMed ID: 27575317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homing in on cognition with cross-sectional analysis of sarcopenia-related measurements: the SARCOG study.
    Kara Ö; Kara M; Kaymak B; Kaya TC; Çıtır BN; Durmuş ME; Durmuşoğlu E; Doğan Y; Tiftik T; Turan G; Gürçay E; Analay P; Ocak H; Şener FE; Özçakar L
    Aging Clin Exp Res; 2022 Sep; 34(9):2149-2154. PubMed ID: 35583720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.